Access to anti-retroviral drugs, female in Zambia

Zambia: Access to anti-retroviral drugs, female was 96.0% in 2024. ◆ Volatile

Latest (2024)
96.0%
Change on year
up 2.1%
World rank
14th
of 141 countries
All-time high
96.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, female in Zambia, 2000–2024

0204060801002000201220242000: 0 %2001: 0 %2002: 0 %2003: 2 %2004: 4 %2005: 7 %2006: 11 %2007: 20 %2008: 28 %2009: 33 %2010: 38 %2011: 44 %2012: 46 %2013: 51 %2014: 59 %2015: 66 %2016: 67 %2017: 70 %2018: 77 %2019: 82 %2020: 89 %2021: 89 %2022: 94 %2023: 94 %2024: 96 %

Source: UNAIDS estimates. Measured in %.

Analysis

Zambia recorded 96.0% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.

That represents a change of up 2.1% on the previous year and up 62.7% over ten years.

Over the whole period, access to anti-retroviral drugs, female in Zambia peaked at 96.0% in 2024 and was at its lowest, 0.0%, in 2000.

That places Zambia 14th out of 141 countries with data for 2024, putting it in the top 10%.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, female in Zambia, year by year

Annual values for Access to anti-retroviral drugs, female (%) in Zambia, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 2.0%
2004 4.0% +100.0%
2005 7.0% +75.0%
2006 11.0% +57.1%
2007 20.0% +81.8%
2008 28.0% +40.0%
2009 33.0% +17.9%
2010 38.0% +15.2%
2011 44.0% +15.8%
2012 46.0% +4.5%
2013 51.0% +10.9%
2014 59.0% +15.7%
2015 66.0% +11.9%
2016 67.0% +1.5%
2017 70.0% +4.5%
2018 77.0% +10.0%
2019 82.0% +6.5%
2020 89.0% +8.5%
2021 89.0% +0.0%
2022 94.0% +5.6%
2023 94.0% +0.0%
2024 96.0% +2.1%

Averages by decade

DecadeAverage LowestHighest Years
2000s 10.5% 0.0% 33.0% 10
2010s 60.0% 38.0% 82.0% 10
2020s 92.4% 89.0% 96.0% 5

Countries ranked near Zambia

  1. 12 Rwanda 97.0% compare
  2. 12 United Arab Emirates 97.0% compare
  3. 14 Liberia 96.0% compare
  4. 14 Sweden 96.0% compare
  5. 14 Togo 96.0% compare
  6. 14 United Kingdom of Great Britain and Northern Ireland 96.0% compare

See the full ranking of 160 places →

More gender data for Zambia

All data for Zambia →

Frequently asked questions

What is access to anti-retroviral drugs, female in Zambia?
Access to anti-retroviral drugs, female in Zambia was 96.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, female recorded in Zambia?
The highest recorded value was 96.0% in 2024.
What is the lowest access to anti-retroviral drugs, female recorded in Zambia?
The lowest recorded value was 0.0% in 2000.
How does Zambia rank for access to anti-retroviral drugs, female?
Zambia ranks 14th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, female rising or falling in Zambia?
Over the last ten years it is up 62.7%. The long-run trend across the full record is volatile.
Where does this Zambia data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, female in Zambia. Statizoid, drawing on UNAIDS estimates. Retrieved 11 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/zambia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/zambia/">Access to anti-retroviral drugs, female in Zambia</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, female (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,925 data points, 2000–2024
Last refreshed

The percentage of adult females living with HIV who are receiving antiretroviral therapy.